etidronate has been researched along with Weight Gain in 3 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the safety and efficacy of combining cyclic sodium etidronate and low-dose norethindrone with a long-acting GnRH agonist (GnRH-a) for prolonged therapy of symptomatic endometriosis." | 9.08 | Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy. ( Fournet, N; Judd, HL; Surrey, ES; Voigt, B, 1995) |
| "To examine the safety and efficacy of combining cyclic sodium etidronate and low-dose norethindrone with a long-acting GnRH agonist (GnRH-a) for prolonged therapy of symptomatic endometriosis." | 5.08 | Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy. ( Fournet, N; Judd, HL; Surrey, ES; Voigt, B, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Surrey, ES | 1 |
| Voigt, B | 1 |
| Fournet, N | 1 |
| Judd, HL | 1 |
| Yamashita, K | 1 |
| Kuwahara, M | 1 |
| Ishizuka, H | 1 |
| Ma, YF | 1 |
| Pan, Z | 1 |
| Jee, WS | 1 |
| Lin, CH | 1 |
| Liang, HH | 1 |
| Chen, H | 1 |
| Pun, S | 1 |
| Li, XJ | 1 |
1 trial available for etidronate and Weight Gain
| Article | Year |
|---|---|
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
Topics: Adult; Bone Density; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administrat | 1995 |
2 other studies available for etidronate and Weight Gain
| Article | Year |
|---|---|
Effect of 1-hydroxyethane-1,1-diphosphonic acid (HEDP) on new bone formation induced by bone matrix gelatin (BMG).
Topics: Animals; Bone and Bones; Bone Demineralization Technique; Bone Matrix; Cartilage; Etidronic Acid; Ge | 1994 |
Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Remodeling; Calcium Channel Blockers; Dinoprostone; Drug | 1997 |